GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » Current Accrued Expense

Lophos Holdings (XCNQ:MESC) Current Accrued Expense : C$0.00 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Lophos Holdings Current Accrued Expense?

Lophos Holdings's Current Accrued Expense for the quarter that ended in Mar. 2024 was C$0.00 Mil.

Lophos Holdings Current Accrued Expense Historical Data

The historical data trend for Lophos Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lophos Holdings Current Accrued Expense Chart

Lophos Holdings Annual Data
Trend Mar22 Mar23 Mar24
Current Accrued Expense
- - -

Lophos Holdings Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only - - - - -

Lophos Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Lophos Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Lophos Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Lophos Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » Current Accrued Expense
Comparable Companies
TSXV:IOT TSX:APLI XCNQ:MBIO TSXV:RP XCNQ:NOVA XCNQ:BIOV XCNQ:GLOW TSXV:MRVL TSXV:RKV TSX:IPCI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
1111 Melville Street, Suite 620, Vancouver, BC, CAN, V6E 3V6
Website
Lophos Holdings Inc is engaged in the y is the cultivation of peyote and the manufacture of Lophophora compounds, including Mescaline, as well as formulation of novel Lophophora-based compounds.
Executives
John Ioannis Karagiannidis Director
Evan Stawnyczy Director

Lophos Holdings Headlines

No Headlines